These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33343566)

  • 1. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
    Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
    Front Immunol; 2020; 11():578019. PubMed ID: 33343566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic BSA-conjugated disaccharide related to the
    Akhmatova NK; Kurbatova EA; Zaytsev AE; Akhmatova EA; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
    Front Immunol; 2024; 15():1388721. PubMed ID: 38840926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoglycoconjugate of Tetrasaccharide Representing One Repeating Unit of the
    Kurbatova EA; Akhmatova NK; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Gening ML; Nifantiev NE
    Front Immunol; 2017; 8():659. PubMed ID: 28626461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SYNTHETIC CONJUGATED ANALOGUES OF CAPSULE POLYSACCHARIDES OF PNEUMOCOCCUS - AN INSTRUMENT FOR DETECTION OF POST-VACCINATION ANTIBODIES].
    Kurbatova EA; Akhmatova EA; Akhmatova NK; Egorova NB; Yastrebova NE; Sukhova EV; Tsvetkov YE; Yashunsky DV; Nifantiev NE
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Nov; (6):54-60. PubMed ID: 30695390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate Specificity and Isotypes of Monoclonal and Polyclonal Antibodies to Conjugated Tetrasaccharide, a Synthetic Analogue of Repeating Unit of Capsular Polysaccharide of Streptococcus Pneumoniae Serotype 14.
    Kurbatova ЕА; Yakovleva IV; Akhmatova EА; Sukhova ЕV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
    Bull Exp Biol Med; 2019 Feb; 166(4):477-480. PubMed ID: 30788740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EPITOPIC SPECIFICITY OF A SYNTHETIC DISACCHARIDE, RECURRING LINK OF CAPSULE POLYSACCHARIDE CHAIN OF SEROTYPE 3 STREPTOCCUS PNEUMONIAE].
    Kurbatova EA; Akhmatova NK; Egorova NB; Semenova IB; Yastrebova NE; Tsvetkov YE; Sukhova EV; Yashunsky DV; Nifantiev NE
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):46-53. PubMed ID: 26259269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
    Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
    Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenic activity of a conjugate of synthetic hexasaccharide related to a streptococcus pneumoniae serotype 14 capsule polysaccharide chain fragment].
    Kurbatova EA; Vorob'ev DS; Egorova NB; Semenova IB; Sukhova EV; Iashunskiĭ DV; Tsvetkov IuE; Nifant'ev NÉ
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):56-63. PubMed ID: 24605676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
    Mawas F; Feavers IM; Corbel MJ
    Vaccine; 2000 Dec; 19(9-10):1159-66. PubMed ID: 11137252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
    Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
    Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
    Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of aluminium hydroxide on innate immunity and immunogenicity of bacterial and synthetic antigens of Streptococcus pneumoniae].
    Kurbatova EA; Akhmatov ÉA; Akhmatova NK; Vorob'ev DS; Egorova NB; Baturo AP; Romanenko ÉE; Tsvetkov IuE; Sukhova EV; Iashunskiĭ DV; Nifant'ev NÉ
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):59-67. PubMed ID: 25816515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197.
    Mawas F; Niggemann J; Jones C; Corbel MJ; Kamerling JP; Vliegenthart JF
    Infect Immun; 2002 Sep; 70(9):5107-14. PubMed ID: 12183560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
    J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
    Lefeber DJ; Benaissa-Trouw B; Vliegenthart JF; Kamerling JP; Jansen WT; Kraaijeveld K; Snippe H
    Infect Immun; 2003 Dec; 71(12):6915-20. PubMed ID: 14638780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Pneumococcal Protein-Polysaccharide Conjugate Vaccine Based on Biotin-Streptavidin.
    Guo M; Guo X; Zhang C; Zhu S; Zhang Y; Gu T; Kong W; Wu Y
    Infect Immun; 2022 Jan; 90(1):e0035221. PubMed ID: 34694917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
    Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
    J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.
    Safari D; Dekker HA; Joosten JA; Michalik D; de Souza AC; Adamo R; Lahmann M; Sundgren A; Oscarson S; Kamerling JP; Snippe H
    Infect Immun; 2008 Oct; 76(10):4615-23. PubMed ID: 18678667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.
    Parameswarappa SG; Reppe K; Geissner A; Ménová P; Govindan S; Calow ADJ; Wahlbrink A; Weishaupt MW; Monnanda BP; Bell RL; Pirofski LA; Suttorp N; Sander LE; Witzenrath M; Pereira CL; Anish C; Seeberger PH
    Cell Chem Biol; 2016 Nov; 23(11):1407-1416. PubMed ID: 27818299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.